$204,359,786
to FRED HUTCHINSON CANCER CENTER
LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HIV PREVENTION TRIALS NETWORK
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Latest obligation on the HIV Prevention Trials Network, an NIH-funded clinical research program since 2006 testing HIV prevention strategies.
Sustains U.S. HIV prevention research infrastructure; trials develop and test vaccine candidates and intervention strategies to reduce new infections.
Coordinates HIV vaccine and prevention drug testing across multiple research sites; connects NIH-funded research to downstream pharmaceutical development pipelines.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-07-02. Cost: $0.018503.
- 2026-06-05LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIALS NETWORK$1.1B
- 2026-05-21HVTN LABORATORY PROGRAM$443.7M
- 2026-05-21LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HIV VACCINE TRIALS NETWORK$383.5M
- 2026-05-21CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)$221.9M
- 2026-04-20EARLY DETECTION RESEARCH NETWORK: DATA MANAGEMENT AND COORDINATING CENTER$67.7M
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UM1AI068617_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.